Artemether–lumefantrine | Study site | ||||
---|---|---|---|---|---|
Massinga (N = 95) | Moatize (N = 92) | Montepuez (N = 90) | Mopeia (N = 91) | Total (N = 368) | |
Vomiting n (%) | 1 (1.1) | 1 (1.1) | 1 (1.1) | 0 (0) | 3 (0.8) |
Diarrhoea n (%) | 0 (0) | 0 (0) | 1 (1.1) | 0 (0) | 1 (0.3) |
Weakness n (%) | 0 (0) | 0 (0) | 1 (1.1) | 1 (1.1) | 2 (0.5) |
Dizziness n (%) | 0 (0) | 1 (1.1) | 3 (3.3) | 1 (1.1) | 5 (1.4) |
Fainting n (%) | 0 (0) | 0 (0) | 1 (1.1) | 1 (1.1) | 2 (0.5) |
Pruritus n (%) | 0 (0) | 0 (0) | 1 (1.1) | 1 (1.1) | 2 (0.5) |
Urticaria n (%) | 0 (0) | 1 (1.1) | 3 (3.3) | 3 (3.3) | 7 (1.9) |
Artesunate–amodiaquine | Massinga (N = 92) | Moatize (N = 0) | Montepuez (N = 90) | Mopeia (N = 91) | Total (N = 273) |
---|---|---|---|---|---|
Vomiting n (%) | 1 (1.1) | NA | 1 (1.1) | 0 (0) | 2 (0.7) |
Diarrhoea n (%) | 1 (1.1) | NA | 1 (1.1) | 0 (0) | 2 (0.7) |
Weakness n (%) | 0 (0) | NA | 1 (1.1) | 0 (0) | 1 (0.4) |
Dizziness n (%) | 0 (0) | NA | 1 (1.1) | 0 (0) | 1 (0.4) |
Fainting n (%) | 0 (0) | NA | 2 (2.2) | 0 (0) | 2 (0.7) |
Pruritus n (%) | 0 (0) | NA | 1 (1.1) | 0 (0) | 1 (0.4) |
Urticaria n (%) | 1 (1.1) | NA | 1 (1.1) | 0 (0) | 2 (0.7) |